You are here : English versionteamsNNP

Neurogenomics and Neuronal Physiopathology

The focus on glutamatergic signaling and metabolism is supported by previous accumulated evidence from the team reporting various genetic alterations affecting the structure, the development and/or the function of excitatory glutamatergic neuronal connections in patients with neurodevelopmental disorders (ID and/or autism), as well as abnormal molecular signatures supporting perturbations in glutamate initiated signaling pathways and converging towards glutamate‐mediated excitotoxicity in ALS.

 

Members (Phd students excluded)

 
ANDRES Christian PUPH1
ARPIN Stéphanie PH
AUGÉ-GOUILLOU Corinne PU1
BENZ DE BRETAGNE Isabelle PH
BLASCO Hélène  MCUPH
CHERPI- ANTAR Catherine TCH
CORCIA Philippe PUPH
COUDERT Edouard ATER
DE TOFFOL Bertrand PUPH1
GENTY Murielle ADT
JAILLET Jérôme TCH
LAUMONNIER Frédéric CR1
LEVER David CDI.C
LIMOUSIN Nadège PH
MAROUILLAT Sylviane IE
MINIER Frédéric MCF
MOIZARD Marie-Pierre IR
RAYNAUD Martine PH
RENAULT Sylvaine MCF
RONCE Nathalie IR
THEPAULT Rose-Anne TCH
TOUTAIN Annick PUPH
UNG Devina ATER
VONWILL Sandrine IR
VOURC'H Patrick PUPH